Hepcinat LP (Ledipasvir 90mg and sofosbuvir 400mg)

Trade Name: - HEPCINAT-LP

Drug Form: - Medicine is available in the form of Tablets Generic Name: - The generic name is Ledipasvir International Trade Name: - Harvoni (Gilead Sciences, Inc.) Manufactured by: - NATCO PHARMA LTD Active Ingredients: - Ledipasvir 90mg and Sofosbuvir 400mg Packing: - Pack of 28 Tablets

Description: Hepatitis C is a viral infection that causes inflammation of the liver. Genotypes are used to identify particular strains of HCV which are based upon differences in particular regions of the viral genome.

HARVONI (Gilead Sciences, Inc.) is a prescription medicine which contains a combination of Sofosbuvir and Ledipasvir in the dosages form of 90mg and 400 mg that is used for treatment of Chronic Hepatitis C (CHC) genotype 1 infection in adults. It is not recognized yet if HARVONI is safe and effective medicine for children under 18 years of age.

Genotype 1 HCV is the most common infection accounting for 70 to 75% of the entirely Hepatitis C infections in the UNITED STATES.

Ledipasvir and Sofosbuvir are antiviral medications that help to prevent hepatitis C virus (HCV) cells from multiplying in your body.

We are available for our clients round the clock and can also be reached on WhatsApp, Viber online social apps on the internet.

For more details please contact us Charitable Foundation "Healthy Nation" Email: healthynation.ua@gmail.com